Defining the functional targets of cap'n'collar transcription factors NRF1, NRF2, and NRF3
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
The NRF transcription factors NRF1, NRF2, and NRF3, are a subset of Cap‘n’collar transcriptional regulators which modulate the expression of genes harboring antioxidant-response element (ARE) sequences within their genomic loci. Despite the emerging physiological importance of NRF family members, the repertoire of their genetic targets remains incompletely defined. Here we use RNA-sequencing-based transcriptional profiling and quantitative proteomics to delineate the overlapping and differential genetic programs effected by the three NRF transcription factors. We then create consensus target gene sets regulated by NRF1, NRF2, and NRF3 and define the integrity of these gene sets for probing NRF activity in mammalian cell culture and human tissues. Together, our data provide a quantitative assessment of how NRF family members sculpt proteomes and transcriptomes, providing a framework to understand the critical physiological importance of NRF transcription factors and to establish pharmacologic approaches for therapeutically activating these transcriptional programs in disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, NRF3 drive a more selective transcriptional program 7 , a feature that could potentially reduce off-target effects.”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Unlike its broadly expressed counterparts NRF1 and NRF2, NRF3 displays uneven tissue distribution.”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1×
“The targets of NRF members were verified at the transcript and protein level by statistical significance testing and were then analyzed by pathway association programs such as Gene Set Enrichment Analysis (GSEA) [27,28] and Database for Annotation, Visualization and Integrated Discovery (DAVID) [29], as discussed belo…”
MethodSystematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · cited 1×
“The targets of NRF members were verified at the transcript and protein level by statistical significance testing and were then analyzed by pathway association programs such as Gene Set Enrichment Analysis (GSEA) [27,28] and Database for Annotation, Visualization and Integrated Discovery (DAVID) [29], as discussed belo…”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“The targets of NRF members were verified at the transcript and protein level by statistical significance testing and were then analyzed by pathway association programs such as Gene Set Enrichment Analysis (GSEA) [27,28] and Database for Annotation, Visualization and Integrated Discovery (DAVID) [29], as discussed belo…”
MethodEng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“Protein identification and quantification were performed using the Integrated Proteomics Pipeline (IP2) [21,22].”
MethodRole of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903 · cited 1×
“A related effort determined that NRF2 knockout animals while displaying no overt developmental defects, are prone to carcinogenesis, and are critically sensitive to oxidative stress [4].”
BackgroundItoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · cited 1×
“A seminal contribution supporting this hypothesis was the early association of NRF2 to the inducible transcriptional upregulation of genes containing ARE sites within their promoters [3].”
BackgroundThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297 · cited 1×
“Further, deregulated NRF2 activity has been associated with various disease states such as cancer [7], neurodegeneration [8], inflammation [9], and diabetes [10].”
BackgroundStress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776 · cited 5×
“In the nucleus, NRF transcription factors dimerize with small MAF proteins (small musculoaponeurotic fibrosarcoma; MAFF, MAFG, and MAFK) to modulate the transcription of genes containing antioxidant response elements (AREs; consensus sequence = TGABNNGC) within their genomic loci [1].”
BackgroundInfluentialShivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693
SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans
Blackwell, T. K., Steinbaugh, M. J., Hourihan, J. M., Ewald, C. Y., & Isik, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.008 · Cited by 622
Cited by
Fundamentals of redox regulation in biology
Sies, H., Mailloux, R. J., & Jakob, U. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00730-2 · Cited by 502
Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis
Wang, Y., Lu, J., Carisey, A. F., Chadchan, S. B., Lee, H. W., Malireddi, R. K. S., Sharma, B. R., Nagakannan, P., Tweedell, R. E., Palacios, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.002 · Cited by 110
CISD2 maintains cellular homeostasis
Shen, Z., Huang, Y., Teng, Y., Wang, T.-W., Kao, C., Yeh, C., & Tsai, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118954 · Cited by 87
Liu, X., Huang, L., Zhang, X., & Xu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140221 · Cited by 78
Boas, S. M., Joyce, K. L., & Cowell, R. M. (2021) · Antioxidants · doi:10.3390/antiox11010008 · Cited by 73
“More recently, studies using chromatin immunoprecipitation (ChIP) assays have identified overlapping targets for the NRF family members for genes involved in RNA metabolism, development, and the unfolded protein response [79,80].”
BackgroundSykiotis, G. P. (2021) · Antioxidants · doi:10.3390/antiox10060828 · Cited by 73
“An unexpected finding was that the basal expression of most Nrf1, Nrf2 and Nrf3 core consensus gene sets was not coregulated across tissues, but the gene sets instead displayed tissue-specific preferences in their expression, such that genes co-regulated within one organ were often not correlated within another organ…”
BackgroundMethodInfluentialRegulation and Functions of the ER-Associated Nrf1 Transcription Factor
Ruvkun, G., & Lehrbach, N. J. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041266 · Cited by 64
HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System
Cyran, A. M., & Zhitkovich, A. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00131 · Cited by 58
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling
Ko, Y., Hong, M., Lee, S., Kumar, M., Ibrahim, L. H., Nutsch, K., Stanton, C. R., Sondermann, P., Sandoval, B. A., Bulos, M. L., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300763120 · Cited by 53
“Nuclear factor erythroid 2-related factor 2, NRF2, is a cap’n’collar (CNC) basic leucine zipper transcription factor (TF) that serves as the master regulator of oxidative stress resistance in mammalian cells (1, 2).”
BackgroundSelf-citationProteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
Buttari, B., Tramutola, A., Rojo, A. I., Chondrogianni, N., Saha, S., Berry, A., Giona, L., Miranda, J. P., Profumo, E., Davinelli, S., et al. (2025) · Biomolecules · doi:10.3390/biom15010113 · Cited by 49
“Research has shown that NRF2 can enhance HSF1 transcription during OS in human fibrosarcoma cells [32], and NRF2 overexpression in HEK293T cells increases the RNA levels of chaperones like HSPA4, HSPA8, and HSPA9 [33].”
Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management
Khan, S. U., Khan, S. U., Suleman, M., Khan, S. U., Suleman, M., Arbi, F. M., Hussain, T., Alsuhaibani, A. M., & Refat, M. S. E.-D. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102084 · Cited by 48
Targeting Nrf2 with Probiotics and Postbiotics in the Treatment of Periodontitis
Karaca, B., Yılmaz, M., & Gürsoy, U. K. (2022) · Biomolecules · doi:10.3390/biom12050729 · Cited by 48
“lating anti-oxidative response element genes [24].”
BackgroundSuccinylation of a KEAP1 sensor lysine promotes NRF2 activation
Ibrahim, L. H., Stanton, C. R., Nutsch, K., Nguyen, T. T. A., Li-Ma, C., Ko, Y., Lander, G. C., Wiseman, R. L., & Bollong, M. J. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.014 · Cited by 39
Self-citationRole of Nrf2 in Pancreatic Cancer
Cykowiak, M., & Krajka‐Kuźniak, V. (2021) · Antioxidants · doi:10.3390/antiox11010098 · Cited by 37
“There are also two other members of the Nrf subfamily: Nrf1 and Nrf3 [22].”
BackgroundDou, R., Wang, X., & Zhang, J. (2022) · BioMed Research International · doi:10.1155/2022/8672258 · Cited by 35
“All three NFE2 TFs bind to the ARE (antioxidant-response element) region and activate the expression of targeted genes, including those encoding ferritin, heme oxygenase 1, and metallothionein [5, 6].”
Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling
Roberts, J. A., Rainbow, R. D., & Sharma, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076723 · Cited by 35
“There is growing evidence supporting the rationale that NRF1 may also play a critical role in normal physiological functions, which may include mediating proteasomal responses, chaperone transcription and protein quality control mechanisms [24,25].”
BackgroundRosarda, J. D., Baron, K. R., Nutsch, K., Kline, G. M., Stanton, C. R., Kelly, J. W., Bollong, M. J., & Wiseman, R. L. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00810 · Cited by 34
“To test this, we initially monitored the activation of the NRF2 selective ARE-luciferase reporter (ARELUC) in HT22 cells treated with AA147 analogs that disrupt compound metabolic activation (20, 34).”
Self-citationGenetic Variations on Redox Control in Cardiometabolic Diseases: The Role of Nrf2
Zazueta, C., Jiménez‐Uribe, A. P., Pedraza‐Chaverrí, J., & Buelna‐Chontal, M. (2022) · Antioxidants · doi:10.3390/antiox11030507 · Cited by 32
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
Emanuele, S., Celesia, A., D’Anneo, A., Lauricella, M., Carlisi, D., Blasio, A. D., & Giuliano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157963 · Cited by 31
Chen, C., Chen, Y., Zhang, Z.-H., Jia, S.-Z., Chen, Y., Huang, S. L., Xu, X.-W., & Song, G.-L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.750921 · Cited by 31
“NRF2 prefers binding to antioxidant-response elements flanked by GC-rich regions and NRF1 prefers AT-rich flanking regions (Liu et al., 2019; Ibrahim et al., 2020).”
BackgroundSzaefer, H., Licznerska, B. E., & Baer‐Dubowska, W. (2024) · Molecules · doi:10.3390/molecules29184283 · Cited by 28
“There are two other members of the Nrf subfamily, Nrf1 and Nrf3, in addition to Nrf2 [30].”
BackgroundLipid Peroxidation-Related Redox Signaling in Osteosarcoma
Šunjić, S. B., Jaganjac, M., Vlainić, J., Halasz, M., & Žarković, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084559 · Cited by 27
“Some of the genes are responsible for protecting cells from ROS: heme oxygenase 1 (HMOX1), GCLc, GCLm , GSS, GST, GR, SOD1, CAT, TRX, TXNRD1, SRX, PRDX1, drug transport (MRP gene family), quinone 1 (NQO1), NAD(P)H dehydrogenase, etc. [185,187–189].”
BackgroundLuo, Y., Jiang, L., Liao, Z., Wang, Y.-Y., Wang, Y., & Xiao, X. (2024) · Immunology · doi:10.1111/imm.13875 · Cited by 21
Baron, K. R., Oviedo, S., Krasny, S., Zaman, M., Aldakhlallah, R., Bora, P., Mathur, P., Pfeffer, G., Bollong, M. J., Shutt, T. E., et al. (2025) · eLife · doi:10.7554/elife.100541.3 · Cited by 21
Self-citationWang, M., Ren, Y., Hu, S., Liu, K., Qiu, L., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.707032 · Cited by 20
Chandran, A., Oliver, H., & Rochet, J. (2023) · Biology · doi:10.3390/biology12091169 · Cited by 19
“Moreover, HEK293T cells overexpressing NFE2L1 were found to have increased levels of RNAs encoding molecular chaperones, including HSPA4, HSPA8, and HSPA9 [171].”
Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer
Zhang, H., Liu, Y., Zhang, K., Hong, Z., Liu, Z., Liu, Z., Li, G., Xu, Y., Pi, J., Fu, J., et al. (2024) · Antioxidants · doi:10.3390/antiox13070758 · Cited by 16
“By using sequencing technology and bioinformatics methods, the new physiological function and novel downstream genes of NFE2L1 can be discovered [96,97].”
NRF3 activates mTORC1 arginine-dependently for cancer cell viability
Hirose, S., Waku, T., Tani, M., Masuda, H., Endo, K., Ashitani, S., Aketa, I., Kitano, H., Nakada, S., Wada, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106045 · Cited by 15
Small-molecule activators of NRF1 transcriptional activity prevent protein aggregation
Sedláček, J., Šmahelová, Z., Adamek, M., Subova, D., Svobodová, L., Kadlecová, A., Majer, P., Machara, A., & Šašková, K. G. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117864 · Cited by 15
Yan, H., Wang, Y., Liang, H., Duan, Y., Wang, J., Zhou, C., & Huang, Z. W. (2025) · Biology · doi:10.3390/biology14010090 · Cited by 14
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5
Gurri, S., Siegenthaler, B., Cangkrama, M., Restivo, G., Huber, M., Saliba, J., Dummer, R., Blank, V., Hohl, D., & Werner, S. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317761 · Cited by 13
“…did not observe significant differences NRF3 has a known function as transcription factor and was reported to regulate some of the NRF2 target genes, but also genes that are not controlled by NRF2 (Pepe et al , 2010; Liu et al , 2019; Ibrahim et al , 2020; Waku et al , 2021; Saliba et al , 2022).”
BackgroundDecoding the NRF2–NOTCH Crosstalk in Lung Cancer—An Update
Sparaneo, A., Torrisi, F., D’Angeli, F., Giurdanella, G., Bravaccini, S., Muscarella, L. A., & Fabrizio, F. P. (2025) · Antioxidants · doi:10.3390/antiox14060657 · Cited by 12
Protein sequence editing defines distinct and overlapping functions of SKN-1A/Nrf1 and SKN-1C/Nrf2
Jochim, B., Topalidou, I., & Lehrbach, N. J. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011780 · Cited by 12
NGLY1: insights from Caenorhabditis elegans
Lehrbach, N. J. (2021) · The Journal of Biochemistry · doi:10.1093/jb/mvab112 · Cited by 12
Xing, P., Chen, Z., Zhu, W., Lin, B., & Quan, M. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2416221 · Cited by 11
“17 In the TME, NRF3 can influence the expression of genes related to inflammation and immune regulation.”
BackgroundSun, S., Wang, C., Hu, J., Zhao, P. F., Wang, X., & Balch, W. E. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101917 · Cited by 9
Metabolically activated proteostasis regulators that protect against erastin-induced ferroptosis
Kline, G. M., Madrazo, N., Cole, C. M., Pannikkat, M., Bollong, M. J., Rosarda, J. D., Kelly, J. W., & Wiseman, R. L. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00027g · Cited by 9
Self-citationZhang, Y., Chen, X., Wang, M., Zhu, Y., Shi, W., Li, C., Zhang, Z., Taniguchi, H., & Ao, P. (2025) · Cell Stress · doi:10.15698/cst2025.07.306 · Cited by 8
Wang, Y., Yan, H., Liang, H., Duan, Y., Wang, J., Zhou, C., & Huang, Z. W. (2025) · Antioxidants · doi:10.3390/antiox14101209 · Cited by 7
“The Hippo pathway regulates the downstream YAP/TAZ transcription factors, which influence the gene expression of antioxidant enzymes and increase the resistance to environmental stress [45].”
NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma
Immonen, A., Haapasaari, K., Skarp, S., Karihtala, P., & Teppo, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2240223 · Cited by 7
“Immunohistochemical expression of NRF3 was then studied in a sample set of benign and dysplastic naevi, melanomas, and their lymph node metastases showing that similar to NRF2 and NRF1 [17], NRF3 was also downregulated during melanoma carcinogenesis at the protein level.”
InfluentialActivation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs
Sedláček, J. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00408 · Cited by 6
The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment
Yan, L., Li, X., Xu, J., Tang, S., Wang, G., Shi, M., & Liu, P. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167794 · Cited by 6
Ding, Z., Zheng, M., Mou, B., Li, Y., Qin, B., Qiu, L., Yang, X., & Ren, Y. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124200 · Cited by 6
Li, J., Arest, S., Olszowy, B., Gordon, J. C., Barrero, C. A., & Perez-Leal, O. (2023) · Antioxidants · doi:10.3390/antiox12071363 · Cited by 6
Jiang, M., Zhang, K., Li, M., Tian, Y., Wang, T., Rodríguez, R. A., Lin, Z., Meng, J., Li, C., Wang, Z., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02615-8 · Cited by 5
“Furthermore, NRF2 (Nuclear factor erythroid 2-related factor 2) is a transcription factor that regulates the expression of antioxidant proteins [161].”
Chu, J., Zhao, Q., Wang, Y., Cai, C., Cui, X., Zhang, N., Xu, T., Dou, H., Wang, F., Yu, F., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157923 · Cited by 4
Cai, B.-Q., Chen, W.-M., Chen, M.-W., Chen, Y., & Tang, J. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0790 · Cited by 4
Zakić, T., Stojanovic, S., Janković, A., Korać, A., Pekovic‐Vaughan, V., & Korać, B. (2022) · BioFactors · doi:10.1002/biof.1931 · Cited by 4
“Moreover, the extent to which these three transcription factors overlap has only been evaluated in two previously published papers.(19,20) Additionally, the cross-talk between Nrf2 and a mitochondrial transcription factor, nuclear respiratory factor 1 (NRF1), has been the subject of intense research.”
BackgroundNing, H., Yang, Q., Ren, Y., & Qiu, L. (2024) · Discover Oncology · doi:10.1007/s12672-024-01574-0 · Cited by 4
Targeting NFE2L1 signalling with small molecules to protect against Ferroptosis
Svobodová, L., Sedláček, J., Šmahelová, Z., Majer, P., Machara, A., & Šašková, K. G. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130425 · Cited by 4
Investigating NFE2L1 activators for targeted protein aggregate clearance: a follow-up study
Šmahelová, Z., Svobodová, L., Sedláček, J., Adamek, M., Polidarova, M. P., Majer, P., Machara, A., & Šašková, K. G. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00584a · Cited by 3
“28,32 Brain-specific deletion of NFE2L1 in mice results in age-related accumulation of polyubiquitinated protein aggregates and neuronal atrophy, recapitulating hallmark features of neurodegenerative disorders.”
Baron, K. R., Oviedo, S., Krasny, S., Zaman, M., Aldakhlallah, R., Mathur, P., Pfeffer, G., Bollong, M. J., Shutt, T. E., Grotjahn, D. A., et al. (2024) · eLife · doi:10.7554/elife.100541.1 · Cited by 3
Self-citationTopalidou, I., & Lehrbach, N. J. (2026) · GeroScience · doi:10.1007/s11357-026-02146-6 · Cited by 2
NGLY1 Deficiency: A Rare Genetic Disorder Unlocks Therapeutic Potential for Common Diseases
Walber, S., Partalidou, G., & Gerling‐Driessen, U. I. M. (2022) · Israel Journal of Chemistry · doi:10.1002/ijch.202200068 · Cited by 2
p53 engagement is a hallmark of an unfolded protein response in the nucleus of mammalian cellsPreprint
Park, J. H., & Wandless, T. J. (2025) · eLife · doi:10.7554/elife.105021 · Cited by 2
Baron, K. R., Oviedo, S., Krasny, S., Zaman, M., Aldakhlallah, R., Bora, P., Mathur, P., Pfeffer, G., Bollong, M. J., Shutt, T. E., et al. (2025) · eLife · doi:10.7554/elife.100541.2 · Cited by 2
Self-citationTargeting autophagy to treat neointimal hyperplasia in vascular disease
Yan, R., Tual-Chalot, S., & Stellos, K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf104 · Cited by 1
Nrf3: an emerging player in cancer, inflammation, and cellular homeostasis
Kilicaslan, D., Irmak-Yazicioglu, M. B., & Copuroglu, E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11678-1 · Cited by 2
“Integrated RNA sequencing and quantitative proteomic analyses have shown that Nrf3 modulates the expression of 176 upregulated and 404 downregulated transcripts, a considerably smaller set compared to Nrf1 and Nrf2 [41].”
Psarias, G., Ziros, P. G., Mageiropoulou, A., Chartoumpekis, D. V., Habeos, G. I., Alomair, B. M., Duntas, L. H., Trougakos, I. P., & Sykiotis, G. P. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104222 · Cited by 1
“Electrophilic compounds like pristimerin may generate higher intracellular ROS levels in the absence of Nrf2; this heightened oxidative stress could trigger compensatory activation of alternative ARE-binding transcription factors such as Nrf3 [78,79].”
p53 engagement is a hallmark of an unfolded protein response in the nucleus of mammalian cellsPreprint
Park, J. H., & Wandless, T. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.08.622663 · Cited by 1
“Since the RNA-Seq analysis showed that both NucDD and CytoDD induced gene products of these transcription factors (Ibrahim et al., 2020), we also immunoblotted for 10 cellular levels of Nrf1 and Nrf2 following Shield-1 withdrawal (Fig.”
Chang, W.-H., Vaughan, A. J., Stamey, A. G., Mancini, M., Hayashi, M., Yang, R. Y., Robb, R. N., Andrussier, D., Klomp, J. A., Waters, A. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.18.719329 · Cited by 1
Asker, M. H., Mohammed, N. S., & Zamil, Z. S. (2024) · Journal of Animal Health and Production · doi:10.17582/journal.jahp/2024/12.4.458.465
p53 engagement is a hallmark of an unfolded protein response in the nucleus of mammalian cellsPreprint
Park, J. H., & Wandless, T. J. (2025) · eLife · doi:10.7554/elife.105021.1
Baron, K. R., Oviedo, S., Krasny, S., Zaman, M., Aldakhlallah, R., Bora, P., Mathur, P., Pfeffer, G., Bollong, M. J., Shutt, T. E., et al. (2025) · eLife · doi:10.7554/elife.100541.3.sa4
Self-citationSchönknecht, N. (2023) · Uppsala University Publications (Uppsala University)
Omoboyowa, D. A., Ojo, F. E., Samuel, M., Leleji, S., Okeyomi, D. V., & Joshua, P. E. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100382
Dreno, L., Ousalem, F., Albornoz-Loaiza, A., CELIK, B., Tiraboschi, C., Claps, G., Al-Nakouzi, N., Compagno, D., Dayris, T., Aglave, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.18.700172
“We therefore compared our buffering gene set (1,391 genes) with NFE2L1 and NFE2L2 target genes identified in human cells by ChIP-seq (44) or by transcriptomic and proteomic analyses (45) .”
A comprehensive review of the emerging role of NRF3 in ovarian cancer tumorigenesis and progression
Hosseinzadeh, M., Karimi, A., Rashid, M., & Sadeghi, M. R. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-01987-1
“In a subsequent study, Ibrahim et al. (2020) sought to delineate the regulatory programs of NRF1, NRF2, and NRF3 using RNA sequencing and quantitative proteomics.”
Neuronutrition: Evaluating the Efficacy of Natural Compounds in Neurodiversity for Brain Health
Badaeva, A. V., Modafferi, S., Malaguarnera, G., Danilov, A., Danilov, A., Perrone, M., Pranzo, B., Girlando, C., Fazzina, F., Mieli, C., et al. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-11608-6_9
Yang, T., Qiu, C., Li, Y., Zhang, Y., Wang, C., Zhou, J., Chu, Z., Ma, A., Huang, L., Wong, Y. K., et al. (2026) · Advanced Science · doi:10.1002/advs.202520252
“Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a crucial role in regulating cellular defense mechanisms, facilitating adaptation to both oxidative and electrophilic stress [ 40, 41 ] and is a key therapeutic target [ 42 ].”
Bayçumendur, F. E., & Ergün, L. (2026) · Histochemistry and Cell Biology · doi:10.1007/s00418-026-02520-7
“Nrf1 and Nrf2 belong to the Cap‘n’Collar (CNC) family of transcriptional regulators and regulate the transcription of genes containing antioxidant response elements (AREs), thereby contributing to cellular redox homeostasis and oxidative stress responses (Ibrahim et al. 2020).”
Scuto, M. C., Cinzia, L., Zerbo, G., Ledda, C., Isola, G., Musso, N., & Salinaro, A. T. (2026) · Antioxidants · doi:10.3390/antiox15080951
Practical Real-Time Temperature-Series Assays for Quantitative Cellular Target EngagementPreprint
Babić, I., Bavan, D., & Nurmemmedov, E. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7320661
Crossroads of well-being: oral health, neurology, neuronutrition and healthy aging
Popovskaya, K. A., Badaeva, A. V., Kosareva, A., Novikov, V. N., Ab, D., Danilov, A. B., Calabrese, V., Rashan, L. J., Isola, G., Sobin, A., et al. (2026) · Open Medicine · doi:10.1515/med-2026-1515
“Nrf2 is a transcription factor that activates antioxidant response element (ARE)-dependent genes involved in cellular antioxidant defense and cytoprotection [138].”
Covalent Targeting of the SKP1-βTrCP Interface Activates NRF1/2 Signaling
Choi, W., Cao, Y., Glicksman, J., & Bollong, M. J. (2026) · ACS Central Science · doi:10.1021/acscentsci.6c00124
Self-citationClinical implications of NRF3 mRNA and protein expression in ovarian cancer
Hosseinzadeh, M., Madjd, Z., Rashid, M., Kalantari, E., Shokouhi, B., Sayyah-Melli, M., & Sadeghi, M. R. (2026) · Bioimpacts · doi:10.34172/bi.33746
Metadata
- Authors
- Ibrahim, L., Mesgarzadeh, J., Xu, I., Powers, E. T., Wiseman, R. L., & Bollong, M. J.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Bollong, Michael J.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2020-10-21
- Volume
- 9
- Issue
- 10
- Pages
- 1025
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC7588902
- OpenAlex
- W3093989283
- Cited by
- 67
- References
- 31
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 12 · 2023: 9 · 2022: 8 · 2021: 9
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (AG046495)
- National Institute on Aging (R01AG046495)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NRF1, Nrf2, Nrf3, antioxidant response element, transcription factor target genes, gene expression profiling, proteomic profiling, antioxidant response, transcriptional regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.